This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Thoratec LLC
Thoratec LLC, a prominent player in the medical device industry, is headquartered in the United States. Founded in 1996, the company has established itself as a leader in the development of innovative therapies for patients with advanced heart failure. With a focus on ventricular assist devices (VADs) and other circulatory support technologies, Thoratec's products are designed to enhance the quality of life for patients awaiting heart transplants or those who are not candidates for surgery. The company’s flagship products, including the HeartMate series, are renowned for their reliability and effectiveness, setting a high standard in the field. Thoratec's commitment to research and development has led to significant advancements in cardiac care, solidifying its market position as a trusted provider of life-saving medical solutions. With a strong presence in North America and expanding operations globally, Thoratec continues to make strides in improving patient outcomes in the cardiovascular sector.
DitchCarbon Score
How does Thoratec LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Thoratec LLC's score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Thoratec LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Abbott Laboratories, which may influence its climate commitments and reporting practices. While Thoratec LLC does not have its own documented reduction targets or climate pledges, it is important to note that any potential climate initiatives or targets may be inherited from its parent company, Abbott Laboratories. Abbott has established science-based targets for emissions reductions, which could cascade down to Thoratec LLC through their corporate relationship. As of now, Thoratec LLC's climate commitments and emissions data remain unspecified, reflecting a broader context within the medical device industry where companies are increasingly focusing on sustainability and carbon footprint reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Thoratec LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
